Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Cholesterol Reactivity Redux

September 8, 2008 | A version of this story appeared in Volume 86, Issue 36

A reactivity study involving cholesterol may provide an alternative explanation for earlier reports suggesting that ozone (O3) is produced in the body and that this event is linked to certain illnesses (J. Am. Chem. Soc., DOI: 10.1021/ja804162d). Prior studies indicate that the immune system generates ozone as part of the inflammatory response. By examining human arterial plaques and brain tissues, the researchers who carried out those studies uncovered unusual cholesterol oxidation products thought to be relevant in disease development. The compounds featured an oxidatively cleaved double bond—the hallmark of an ozonolysis reaction. Now, a team led by Derek A. Pratt of Queen's University, Kingston, Ontario, has found evidence that such reactivity is not unique to ozone. Pratt and coworkers show that the product of the reaction between cholesterol and singlet oxygen—an excited state of O2—undergoes acid-catalyzed decomposition (shown). The product distribution from their laboratory reaction more closely reproduces the observations in the tissues than the distribution from a typical ozonolysis, they say.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.